Exact Mass: 379.1102902

Exact Mass Matches: 379.1102902

Found 117 metabolites which its exact mass value is equals to given mass value 379.1102902, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

S-Lactoylglutathione

(2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-{[(2R)-2-hydroxypropanoyl]sulfanyl}ethyl]carbamoyl}butanoic acid

C13H21N3O8S (379.10493060000005)


S-Lactoylglutathione is a substrate of lactoylglutathione lyase [EC 4.4.1.5] in pyruvate metabolism (KEGG). Another enzyme, glyoxalase I, synthesizes this compound by converting methylglyoxal and reduced glutathione to S-lactoylglutathione. S-D-lactoylglutathione can be hydrolysed by thiolesterases to reduced glutathione and D-lactate but also converted to N-D-lactoylcysteinylglycine and N-D-lactoylcysteine by gamma-glutamyl transferase and dipeptidase (PMID: 8632674). S-lactoylglutathione has also been shown to modulate microtubule assembly (PMID: 690442). [HMDB]. S-Lactoylglutathione is found in many foods, some of which are blackcurrant, oat, pomegranate, and brussel sprouts. S-Lactoylglutathione is a substrate of lactoylglutathione lyase [EC 4.4.1.5] in pyruvate metabolism (KEGG). Another enzyme, glyoxalase I, synthesizes this compound by converting methylglyoxal and reduced glutathione to S-lactoylglutathione. S-D-lactoylglutathione can be hydrolysed by thiolesterases to reduced glutathione and D-lactate but also converted to N-D-lactoylcysteinylglycine and N-D-lactoylcysteine by gamma-glutamyl transferase and dipeptidase (PMID: 8632674). S-lactoylglutathione has also been shown to modulate microtubule assembly (PMID: 690442). Acquisition and generation of the data is financially supported in part by CREST/JST. D000970 - Antineoplastic Agents KEIO_ID L016; [MS3] KO009026 KEIO_ID L016; [MS2] KO009024 KEIO_ID L016

   

SCHEMBL842167

N-acetyl-3-O-(4-deoxy-alpha-L-threo-hex-4-enopyranosyluronic acid)-D-galactosamine

C14H21NO11 (379.1114556)


   

12-Hydroxychelirubine

12-Hydroxydihydrochelirubine

C21H17NO6 (379.1055822)


   

Hyaluronan biosynthesis, precursor 1

(2R,3R,4S)-2-{[(2R,3R,4R,5S,6R)-2,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-4-yl]oxy}-3,4-dihydroxy-3,4-dihydro-2H-pyran-6-carboxylic acid

C14H21NO11 (379.1114556)


This compound belongs to the family of N-acyl-alpha-hexosamines. These are carbohydrate derivatives containing a hexose moeity in which the oxygen atom is replaced by an n-acyl group.

   

(R)-S-lactoylglutathionate(1-)

2-Amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(2-hydroxypropanoyl)sulphanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid

C13H21N3O8S (379.10493060000005)


(R)-S-lactoylglutathionate(1-) is also known as (R)-S-Lactoylglutathionic acid anion. (R)-S-lactoylglutathionate(1-) is considered to be slightly soluble (in water) and acidic

   

2-({6-Amino-3,5-dicyano-4-[4-(cyclopropylmethoxy)phenyl]pyridin-2-yl}sulfanyl)acetamide

2-({6-amino-3,5-dicyano-4-[4-(cyclopropylmethoxy)phenyl]pyridin-2-yl}sulphanyl)acetamide

C19H17N5O2S (379.1102902)


D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058913 - Purinergic Agonists BAY 60-6583 is a potent and high-affinity agonist of adenosine A2B receptor (EC50?= 3 nM) over A1, A2A, and A3 receptors. BAY 60-6583 binds to mouse, rabbit, and dog A2BAR with Ki values of 750 nM, 340 nM and 330 nM, respectively. BAY 60-6583 has a cardioprotective effect in a myocardial ischemia model[1][5].

   

2-Amino-5-[[1-[carboxymethyl(2-hydroxypropanoyl)amino]-1-oxo-3-sulfanylpropan-2-yl]amino]-5-oxopentanoic acid

2-Amino-4-({1-[N-(carboxymethyl)-2-hydroxypropanamido]-1-oxo-3-sulphanylpropan-2-yl}-C-hydroxycarbonimidoyl)butanoic acid

C13H21N3O8S (379.10493060000005)


   

Cyclohexanecarboxamide, N-(2-((ethylsulfonyl)amino)-5-(trifluoromethyl)-3-pyridinyl)-

N-((2-Ethylsulfonylamino)-5-trifluoromethyl-3-pyridyl)cyclohexanecarboxamide monohydrate sodium salt

C15H20F3N3O3S (379.11774060000005)


   
   
   
   

12-Hydroxydihydrochelirubine

12-Hydroxydihydrochelirubine

C21H17NO6 (379.1055822)


A benzophenanthridine alkaloid comprising dihydrochelirubine carrying a hydroxy substituent at the 12-position.

   

2-(4-Hydroxyphenyl)-2-(5-oxopyrrolidine-2-yl)-4-(3,4-dihydroxyphenyl)-4-cyclopentene-1,3-dione

2-(4-Hydroxyphenyl)-2-(5-oxopyrrolidine-2-yl)-4-(3,4-dihydroxyphenyl)-4-cyclopentene-1,3-dione

C21H17NO6 (379.1055822)


   

6-methoxy-13-methyl-13,14-dihydro-[1,3]dioxolo[4,5-i][1,3]dioxolo[4,5:4,5]benzo[1,2-c]phenanthridin-14-ol|Chelirubin|chelirubine

6-methoxy-13-methyl-13,14-dihydro-[1,3]dioxolo[4,5-i][1,3]dioxolo[4,5:4,5]benzo[1,2-c]phenanthridin-14-ol|Chelirubin|chelirubine

C21H17NO6 (379.1055822)


   
   

2-deoxy-N-glycoloyl-9-O-lactoyl-2,3-didehydroneuraminic acid

2-deoxy-N-glycoloyl-9-O-lactoyl-2,3-didehydroneuraminic acid

C14H21NO11 (379.1114556)


   

Dihydrochelirubine -5-Hydroxy

Dihydrochelirubine -5-Hydroxy

C21H17NO6 (379.1055822)


   

Isocoptisine acetate

Pseudocoptisine (acetate)

C21H17NO6 (379.1055822)


   
   

Cys Gly Asn Ser

(2S)-2-[(2S)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-3-carbamoylpropanamido]-3-hydroxypropanoic acid

C12H21N5O7S (379.11616360000005)


   

Cys Gly Ser Asn

(2S)-2-[(2S)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-3-hydroxypropanamido]-3-carbamoylpropanoic acid

C12H21N5O7S (379.11616360000005)


   

Cys Asn Gly Ser

(2S)-2-{2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]acetamido}-3-hydroxypropanoic acid

C12H21N5O7S (379.11616360000005)


   

Cys Asn Ser Gly

2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-hydroxypropanamido]acetic acid

C12H21N5O7S (379.11616360000005)


   

Cys Ser Gly Asn

(2S)-2-{2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanamido]acetamido}-3-carbamoylpropanoic acid

C12H21N5O7S (379.11616360000005)


   

Cys Ser Asn Gly

2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanamido]-3-carbamoylpropanamido]acetic acid

C12H21N5O7S (379.11616360000005)


   

Gly Cys Asn Ser

(2S)-2-[(2S)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-hydroxypropanoic acid

C12H21N5O7S (379.11616360000005)


   

Gly Cys Ser Asn

(2S)-2-[(2S)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-3-hydroxypropanamido]-3-carbamoylpropanoic acid

C12H21N5O7S (379.11616360000005)


   

Gly Asn Cys Ser

(2S)-2-[(2R)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-hydroxypropanoic acid

C12H21N5O7S (379.11616360000005)


   

Gly Asn Ser Cys

(2R)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-sulfanylpropanoic acid

C12H21N5O7S (379.11616360000005)


   

Gly Ser Cys Asn

(2S)-2-[(2R)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

C12H21N5O7S (379.11616360000005)


   

Gly Ser Asn Cys

(2R)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-sulfanylpropanoic acid

C12H21N5O7S (379.11616360000005)


   

Asn Cys Gly Ser

(2S)-2-{2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]acetamido}-3-hydroxypropanoic acid

C12H21N5O7S (379.11616360000005)


   

Asn Cys Ser Gly

2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-hydroxypropanamido]acetic acid

C12H21N5O7S (379.11616360000005)


   

Asn Gly Cys Ser

(2S)-2-[(2R)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-3-sulfanylpropanamido]-3-hydroxypropanoic acid

C12H21N5O7S (379.11616360000005)


   

Asn Gly Ser Cys

(2R)-2-[(2S)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-3-hydroxypropanamido]-3-sulfanylpropanoic acid

C12H21N5O7S (379.11616360000005)


   

Asn Ser Cys Gly

2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-sulfanylpropanamido]acetic acid

C12H21N5O7S (379.11616360000005)


   

Asn Ser Gly Cys

(2R)-2-{2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]acetamido}-3-sulfanylpropanoic acid

C12H21N5O7S (379.11616360000005)


   

Ser Cys Gly Asn

(2S)-2-{2-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanamido]acetamido}-3-carbamoylpropanoic acid

C12H21N5O7S (379.11616360000005)


   

Ser Cys Asn Gly

2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanamido]acetic acid

C12H21N5O7S (379.11616360000005)


   

Ser Gly Cys Asn

(2S)-2-[(2R)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

C12H21N5O7S (379.11616360000005)


   

Ser Gly Asn Cys

(2R)-2-[(2S)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}-3-carbamoylpropanamido]-3-sulfanylpropanoic acid

C12H21N5O7S (379.11616360000005)


   

Ser Asn Cys Gly

2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-sulfanylpropanamido]acetic acid

C12H21N5O7S (379.11616360000005)


   

Ser Asn Gly Cys

(2R)-2-{2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]acetamido}-3-sulfanylpropanoic acid

C12H21N5O7S (379.11616360000005)


   

Chondroitin

(2R,3R,4S)-2-[(2R,3R,4R,5R,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4-dihydroxy-3,4-dihydro-2H-pyran-6-carboxylic acid

C14H21NO11 (379.1114556)


   

Urea, N-(4-chlorophenyl)-N-[2-[(3-cyano-8-methyl-2-quinolinyl)amino]ethyl]- (9CI)

Urea, N-(4-chlorophenyl)-N-[2-[(3-cyano-8-methyl-2-quinolinyl)amino]ethyl]- (9CI)

C20H18ClN5O (379.1199808)


   

Urea, N-(2-chlorophenyl)-N-[2-[(3-cyano-8-methyl-2-quinolinyl)amino]ethyl]- (9CI)

Urea, N-(2-chlorophenyl)-N-[2-[(3-cyano-8-methyl-2-quinolinyl)amino]ethyl]- (9CI)

C20H18ClN5O (379.1199808)


   

Urea, N-(2-chlorophenyl)-N-[2-[(3-cyano-6-methyl-2-quinolinyl)amino]ethyl]- (9CI)

Urea, N-(2-chlorophenyl)-N-[2-[(3-cyano-6-methyl-2-quinolinyl)amino]ethyl]- (9CI)

C20H18ClN5O (379.1199808)


   

6-Oxo-2-phenyl-5-[[(phenylmethoxy)carbonyl]amino]-1(6H)-pyrimidineacetic acid

6-Oxo-2-phenyl-5-[[(phenylmethoxy)carbonyl]amino]-1(6H)-pyrimidineacetic acid

C20H17N3O5 (379.1168152)


   

(S)-Fmoc-2-amino-4,4,4-trifluoro-butyric acid

(S)-Fmoc-2-amino-4,4,4-trifluoro-butyric acid

C19H16F3NO4 (379.10313720000005)


   
   

(1-methylpiperidin-4-yl) 2-chloro-2,2-diphenylacetate,hydrochloride

(1-methylpiperidin-4-yl) 2-chloro-2,2-diphenylacetate,hydrochloride

C20H23Cl2NO2 (379.1105758)


   

4,11-diamino-2-(3-methoxypropyl)-1H-Naphth[2,3-f]isoindole-1,3,5,10(2H)-tetrone

4,11-diamino-2-(3-methoxypropyl)-1H-Naphth[2,3-f]isoindole-1,3,5,10(2H)-tetrone

C20H17N3O5 (379.1168152)


   

(4-N-(Benzhydryloxycarbonyl)cytosine)-1-acetic acid

(4-N-(Benzhydryloxycarbonyl)cytosine)-1-acetic acid

C20H17N3O5 (379.1168152)


   
   
   
   

5-(3-((2S)-(1,4-Benzodioxan-2-ylmethyl)amino)propoxy)-1,3-benzodioxol hydrochloride

5-(3-((2S)-(1,4-Benzodioxan-2-ylmethyl)amino)propoxy)-1,3-benzodioxol hydrochloride

C19H22ClNO5 (379.11864320000007)


   

Fuzapladib

Fuzapladib

C15H20F3N3O3S (379.11774060000005)


C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C2144 - Endothelial-Specific Integrin/Survival Signaling Inhibitor D004791 - Enzyme Inhibitors > D064801 - Phospholipase A2 Inhibitors C308 - Immunotherapeutic Agent > C574 - Immunosuppressant Fuzapladib (IS-741), an orally active leukocyte-function-associated antigen type 1 (LFA-1) activation inhibitor, is a leukocyte adhesion molecule. Fuzapladib is also a phospholipase A2 (PLA2) inhibitor. Fuzapladib exerts anti-inflammatory effects by inhibiting leukocyte migration into the inflammatory site[1][2].

   

gamma-Glutamyl-cysteinyl-glutamic acid

gamma-Glutamyl-cysteinyl-glutamic acid

C13H21N3O8S (379.10493060000005)


   

4-amino-3-(4-ethoxyphenyl)-N-(2-oxolanylmethyl)-2-sulfanylidene-5-thiazolecarboxamide

4-amino-3-(4-ethoxyphenyl)-N-(2-oxolanylmethyl)-2-sulfanylidene-5-thiazolecarboxamide

C17H21N3O3S2 (379.1024276)


   

beta-D-4-deoxy-Delta(4)-GlcpA-(1->3)-beta-D-GalpNAc

beta-D-4-deoxy-Delta(4)-GlcpA-(1->3)-beta-D-GalpNAc

C14H21NO11 (379.1114556)


An amino disaccharide consisting of N-acetyl-beta-D-galactosamine having a 4-deoxy-alpha-L-threo-hex-4-enopyranuronosyl residue attached at the 3-position.

   

(2E,6E)-3,7,11-Trimethyldodeca-2,6,10-trien-1-yl diphosphate

(2E,6E)-3,7,11-Trimethyldodeca-2,6,10-trien-1-yl diphosphate

C15H25O7P2-3 (379.107546)


COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

2-cis,6-trans-Farnesyl diphosphate(3-)

2-cis,6-trans-Farnesyl diphosphate(3-)

C15H25O7P2-3 (379.107546)


   

(2Z,6Z)-farnesyl diphosphate

(2Z,6Z)-farnesyl diphosphate

C15H25O7P2-3 (379.107546)


   

beta-D-4-deoxy-Delta(4)-GlcpA-(1->3)-D-GlcpNAc

beta-D-4-deoxy-Delta(4)-GlcpA-(1->3)-D-GlcpNAc

C14H21NO11 (379.1114556)


   
   

(2E,6Z)-farnesyl diphosphate

(2E,6Z)-farnesyl diphosphate

C15H25O7P2-3 (379.107546)


   

(2R,3R,4S)-2-[(2R,3R,4R,5R)-5-acetamido-4,6-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-3,4-dihydroxy-3,4-dihydro-2H-pyran-6-carboxylic acid

(2R,3R,4S)-2-[(2R,3R,4R,5R)-5-acetamido-4,6-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-3,4-dihydroxy-3,4-dihydro-2H-pyran-6-carboxylic acid

C14H21NO11 (379.1114556)


   

N-[4-(diethylamino)-2-methylphenyl]-2-[(2-nitro-3-thiophenyl)thio]acetamide

N-[4-(diethylamino)-2-methylphenyl]-2-[(2-nitro-3-thiophenyl)thio]acetamide

C17H21N3O3S2 (379.1024276)


   

4-(2,5-dimethoxyphenyl)-3-(3-phenyl-1H-pyrazol-5-yl)-1H-1,2,4-triazole-5-thione

4-(2,5-dimethoxyphenyl)-3-(3-phenyl-1H-pyrazol-5-yl)-1H-1,2,4-triazole-5-thione

C19H17N5O2S (379.1102902)


   

2-(5-chloro-2-pyridinyl)-3-(4-ethoxyanilino)-3H-isoindol-1-one

2-(5-chloro-2-pyridinyl)-3-(4-ethoxyanilino)-3H-isoindol-1-one

C21H18ClN3O2 (379.1087478)


   

(5E)-3-[(2-fluorophenyl)methyl]-5-[[1-(4-fluorophenyl)pyrrol-2-yl]methylidene]imidazolidine-2,4-dione

(5E)-3-[(2-fluorophenyl)methyl]-5-[[1-(4-fluorophenyl)pyrrol-2-yl]methylidene]imidazolidine-2,4-dione

C21H15F2N3O2 (379.1132274)


   

2-[[5-(6-methyl-1H-benzimidazol-2-yl)-2-pyridinyl]thio]-N-(5-methyl-3-isoxazolyl)acetamide

2-[[5-(6-methyl-1H-benzimidazol-2-yl)-2-pyridinyl]thio]-N-(5-methyl-3-isoxazolyl)acetamide

C19H17N5O2S (379.1102902)


   

4-(1-methylsulfonyl-2,3-dihydroindol-5-yl)-N-(2-oxolanylmethyl)-2-thiazolamine

4-(1-methylsulfonyl-2,3-dihydroindol-5-yl)-N-(2-oxolanylmethyl)-2-thiazolamine

C17H21N3O3S2 (379.1024276)


   
   

(R)-S-Lactoylglutathione

(R)-S-Lactoylglutathione

C13H21N3O8S (379.10493060000005)


The S-[(R)-lactoyl] derivative of glutathione. It is an intermediate in the pyruvate metabolism. D000970 - Antineoplastic Agents

   

3-(4-Deoxy-alpha-L-threo-hex-4-enopyranosyluronic acid)-2-acetamido-2-deoxy-D-glucose

3-(4-Deoxy-alpha-L-threo-hex-4-enopyranosyluronic acid)-2-acetamido-2-deoxy-D-glucose

C14H21NO11 (379.1114556)


   

N-acetyl-3-O-(4-deoxy-alpha-L-threo-hex-4-enopyranosyluronic acid)-D-galactosamine

N-acetyl-3-O-(4-deoxy-alpha-L-threo-hex-4-enopyranosyluronic acid)-D-galactosamine

C14H21NO11 (379.1114556)


   

2-({6-Amino-3,5-dicyano-4-[4-(cyclopropylmethoxy)phenyl]pyridin-2-yl}sulfanyl)acetamide

2-({6-Amino-3,5-dicyano-4-[4-(cyclopropylmethoxy)phenyl]pyridin-2-yl}sulfanyl)acetamide

C19H17N5O2S (379.1102902)


D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058913 - Purinergic Agonists BAY 60-6583 is a potent and high-affinity agonist of adenosine A2B receptor (EC50?= 3 nM) over A1, A2A, and A3 receptors. BAY 60-6583 binds to mouse, rabbit, and dog A2BAR with Ki values of 750 nM, 340 nM and 330 nM, respectively. BAY 60-6583 has a cardioprotective effect in a myocardial ischemia model[1][5].

   

beta-D-4-deoxy-Delta(4)-GlcpA-(1->3)-beta-D-GlcpNAc

beta-D-4-deoxy-Delta(4)-GlcpA-(1->3)-beta-D-GlcpNAc

C14H21NO11 (379.1114556)


An amino disaccharide consisting of N-acetyl-beta-D-glucosamine having a 4-deoxy-alpha-L-threo-hex-4-enopyranuronosyl residue attached at the 3-position.

   

3-(4-deoxy-beta-D-gluc-4-enosyluronic acid)-N-acetyl-D-glucosamine

3-(4-deoxy-beta-D-gluc-4-enosyluronic acid)-N-acetyl-D-glucosamine

C14H21NO11 (379.1114556)


An amino disaccharide consisting of N-acetyl-beta-D-glucosamine having a 4-deoxy-alpha-L-threo-hex-4-enopyranuronosyl residue attached at the 3-position.

   

2-trans,6-trans-farnesyl diphosphate(3-)

2-trans,6-trans-farnesyl diphosphate(3-)

C15H25O7P2 (379.107546)


An organophosphate oxoanion that is the trianion obtained by removal of the three protons from the diphosphate group of 2-trans,6-trans-farnesyl diphosphate.

   
   

(3s)-3-[(1r)-1-[(2s,5s)-3,6-dihydroxy-5-[(s)-methanesulfinylmethyl]-2,5-dihydropyrazin-2-yl]ethyl]-3-hydroxy-1-methylindol-2-one

(3s)-3-[(1r)-1-[(2s,5s)-3,6-dihydroxy-5-[(s)-methanesulfinylmethyl]-2,5-dihydropyrazin-2-yl]ethyl]-3-hydroxy-1-methylindol-2-one

C17H21N3O5S (379.12018560000007)


   

3-(1-hydroxyethyl)-6-(1h-indol-3-ylmethyl)-3,6-bis(methylsulfanyl)pyrazine-2,5-diol

3-(1-hydroxyethyl)-6-(1h-indol-3-ylmethyl)-3,6-bis(methylsulfanyl)pyrazine-2,5-diol

C17H21N3O3S2 (379.1024276)


   

4-(3,4-dihydroxyphenyl)-2-(5-hydroxy-3,4-dihydro-2h-pyrrol-2-yl)-2-(4-hydroxyphenyl)cyclopent-4-ene-1,3-dione

4-(3,4-dihydroxyphenyl)-2-(5-hydroxy-3,4-dihydro-2h-pyrrol-2-yl)-2-(4-hydroxyphenyl)cyclopent-4-ene-1,3-dione

C21H17NO6 (379.1055822)


   

(2s)-2-amino-4-{[(1r)-1-(carboxymethyl-c-hydroxycarbonimidoyl)-2-{[(2r)-2-hydroxypropanoyl]sulfanyl}ethyl]-c-hydroxycarbonimidoyl}butanoic acid

(2s)-2-amino-4-{[(1r)-1-(carboxymethyl-c-hydroxycarbonimidoyl)-2-{[(2r)-2-hydroxypropanoyl]sulfanyl}ethyl]-c-hydroxycarbonimidoyl}butanoic acid

C13H21N3O8S (379.10493060000005)


   

5-hydroxy-6-(hydroxymethyl)-3-(1h-indol-3-ylmethyl)-1-methyl-3,6-bis(methylsulfanyl)pyrazin-2-one

5-hydroxy-6-(hydroxymethyl)-3-(1h-indol-3-ylmethyl)-1-methyl-3,6-bis(methylsulfanyl)pyrazin-2-one

C17H21N3O3S2 (379.1024276)


   

3-{1-[3,6-dihydroxy-5-(methanesulfinylmethyl)-2,5-dihydropyrazin-2-yl]ethyl}-3-hydroxy-1-methylindol-2-one

3-{1-[3,6-dihydroxy-5-(methanesulfinylmethyl)-2,5-dihydropyrazin-2-yl]ethyl}-3-hydroxy-1-methylindol-2-one

C17H21N3O5S (379.12018560000007)


   

3-hydroxy-4,5-dimethoxy-6-[2-(5-oxohexyl)-1,3-thiazol-4-yl]pyridine-2-carboximidic acid

3-hydroxy-4,5-dimethoxy-6-[2-(5-oxohexyl)-1,3-thiazol-4-yl]pyridine-2-carboximidic acid

C17H21N3O5S (379.12018560000007)


   

(3s,6r)-5-hydroxy-3-(hydroxymethyl)-6-(1h-indol-3-ylmethyl)-1-methyl-3,6-bis(methylsulfanyl)pyrazin-2-one

(3s,6r)-5-hydroxy-3-(hydroxymethyl)-6-(1h-indol-3-ylmethyl)-1-methyl-3,6-bis(methylsulfanyl)pyrazin-2-one

C17H21N3O3S2 (379.1024276)


   

(3s)-3-[(1r)-1-[(2s,5s)-3,6-dihydroxy-5-[(r)-methanesulfinylmethyl]-2,5-dihydropyrazin-2-yl]ethyl]-3-hydroxy-1-methylindol-2-one

(3s)-3-[(1r)-1-[(2s,5s)-3,6-dihydroxy-5-[(r)-methanesulfinylmethyl]-2,5-dihydropyrazin-2-yl]ethyl]-3-hydroxy-1-methylindol-2-one

C17H21N3O5S (379.12018560000007)


   

(3r)-3-[(1r)-1-[(2s,5r)-3,6-dihydroxy-5-[(r)-methanesulfinylmethyl]-2,5-dihydropyrazin-2-yl]ethyl]-3-hydroxy-1-methylindol-2-one

(3r)-3-[(1r)-1-[(2s,5r)-3,6-dihydroxy-5-[(r)-methanesulfinylmethyl]-2,5-dihydropyrazin-2-yl]ethyl]-3-hydroxy-1-methylindol-2-one

C17H21N3O5S (379.12018560000007)


   

(2r)-4-(3,4-dihydroxyphenyl)-2-[(2r)-5-hydroxy-3,4-dihydro-2h-pyrrol-2-yl]-2-(4-hydroxyphenyl)cyclopent-4-ene-1,3-dione

(2r)-4-(3,4-dihydroxyphenyl)-2-[(2r)-5-hydroxy-3,4-dihydro-2h-pyrrol-2-yl]-2-(4-hydroxyphenyl)cyclopent-4-ene-1,3-dione

C21H17NO6 (379.1055822)


   

(3s,6s)-5-hydroxy-6-(hydroxymethyl)-3-(1h-indol-3-ylmethyl)-1-methyl-3,6-bis(methylsulfanyl)pyrazin-2-one

(3s,6s)-5-hydroxy-6-(hydroxymethyl)-3-(1h-indol-3-ylmethyl)-1-methyl-3,6-bis(methylsulfanyl)pyrazin-2-one

C17H21N3O3S2 (379.1024276)


   

(23s)-12-methoxy-24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,11,14,16,21-octaen-23-ol

(23s)-12-methoxy-24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,11,14,16,21-octaen-23-ol

C21H17NO6 (379.1055822)


   

(4s,5r,6r)-6-{[(3r,4r,5r,6r)-2,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-4-yl]oxy}-4,5-dihydroxy-5,6-dihydro-4h-pyran-2-carboxylic acid

(4s,5r,6r)-6-{[(3r,4r,5r,6r)-2,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-4-yl]oxy}-4,5-dihydroxy-5,6-dihydro-4h-pyran-2-carboxylic acid

C14H21NO11 (379.1114556)


   

12-methoxy-24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,11,14,16,21-octaen-23-ol

12-methoxy-24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,11,14,16,21-octaen-23-ol

C21H17NO6 (379.1055822)


   

(3r)-3-[(1r)-1-[(2s,5r)-3,6-dihydroxy-5-[(s)-methanesulfinylmethyl]-2,5-dihydropyrazin-2-yl]ethyl]-3-hydroxy-1-methylindol-2-one

(3r)-3-[(1r)-1-[(2s,5r)-3,6-dihydroxy-5-[(s)-methanesulfinylmethyl]-2,5-dihydropyrazin-2-yl]ethyl]-3-hydroxy-1-methylindol-2-one

C17H21N3O5S (379.12018560000007)


   

3-hydroxy-4,5-dimethoxy-6-[2-(4-oxohexyl)-1,3-thiazol-4-yl]pyridine-2-carboximidic acid

3-hydroxy-4,5-dimethoxy-6-[2-(4-oxohexyl)-1,3-thiazol-4-yl]pyridine-2-carboximidic acid

C17H21N3O5S (379.12018560000007)


   

(3s,6r)-5-hydroxy-6-(hydroxymethyl)-3-(1h-indol-3-ylmethyl)-1-methyl-3,6-bis(methylsulfanyl)pyrazin-2-one

(3s,6r)-5-hydroxy-6-(hydroxymethyl)-3-(1h-indol-3-ylmethyl)-1-methyl-3,6-bis(methylsulfanyl)pyrazin-2-one

C17H21N3O3S2 (379.1024276)


   

3-hydroxy-4,5-dimethoxy-6-[2-(3-methyl-4-oxopentyl)-1,3-thiazol-4-yl]pyridine-2-carboximidic acid

3-hydroxy-4,5-dimethoxy-6-[2-(3-methyl-4-oxopentyl)-1,3-thiazol-4-yl]pyridine-2-carboximidic acid

C17H21N3O5S (379.12018560000007)


   

(3s,6s)-3-[(1s)-1-hydroxyethyl]-6-(1h-indol-3-ylmethyl)-3,6-bis(methylsulfanyl)pyrazine-2,5-diol

(3s,6s)-3-[(1s)-1-hydroxyethyl]-6-(1h-indol-3-ylmethyl)-3,6-bis(methylsulfanyl)pyrazine-2,5-diol

C17H21N3O3S2 (379.1024276)